高级检索
当前位置: 首页 > 详情页

Telemedicine and Clinical Outcomes in Peritoneal Dialysis: A Propensity-Matched Study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health, Key Laboratory of Renal Disease, Ministry of Education, Beijing, China. [2]Renal Division, Department of Medicine, The Second Hospital of Hebei Medical University, Hebei, China. [3]Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China. [4]Renal Division, Department of Medicine, Peking University Shenzhen Hospital, Guangdong, China. [5]Renal Division, Department of Medicine, The Third Hospital of Hebei Medical University, Hebei, China. [6]Renal Division, Department of Medicine, People's Hospitel of Qinghai Province, Qinghai, China. [7]Renal Division, Department of Medicine, Handan Central Hospital, Hebei, China. [8]Renal Division, Department of Medicine, Peking Haidian Hospital, Beijing, China. [9]Renal Division, Department of Medicine, Shengjing Hospital Affiliated to China Medical University, Jilin, China. [10]Renal Division, Department of Medicine, Cangzhou Central Hospital, Hebei, China. [11]Renal Division, Department of Medicine, The Second Affiliated Hospital of Anhui Medical University, Anhui, China. [12]Renal Division, Department of Medicine, The First Affiliated Hospital of Zhengzhou University, Henan, China. [13]Renal Division, Department of Medicine, Beijing Miyun District Hospital, Beijing, China. [14]Renal Division, Department of Medicine, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China. [15]Renal Division, Department of Medicine, The First Affiliated Hospital of BaoTou Medical College, Neimenggu, China. [16]Renal Division, Department of Medicine, People's Hospital of Langfang, Hebei, China. [17]Renal Division, Department of Medicine, People's Hospital of Gansu, Gansu, China. [18]Renal Division, Department of Medicine, Peking University People's Hospital, Beijing, China. [19]Renal Division, Department of Medicine, Pingdingshan First People's Hospital, Henan, China. [20]Renal Division, Department of Medicine, The First People's Hospital of Xining, Qinghai, China. [21]Renal Division, Department of Medicine, Taiyuan Central Hospital, Shanxi, China. [22]Renal Division, Department of Medicine, Cangzhou People's Hospital, Hebei, China. [23]Renal Division, Department of Medicine, First Hospital of Jilin University, Jilin, China. [24]Renal Division, Department of Medicine, The People's Hospital of Chuxiong Yi Autonomous Prefecture, Yunnan, China. [25]Renal Division, Department of Medicine, The Second Hospital of Shanxi Medical University, Shanxi, China. [26]Renal Division, Department of Medicine, China Rehabilitation Research Center, Beijing Boai Hospital, Beijing, China. [27]Renal Division, Department of Medicine, Beijing Dongzhimen Hospital, Beijing, China. [28]Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing, China.
出处:
ISSN:

摘要:
Telemedicine (TM) has shown to provide potential benefits on clinical outcomes in patients with chronic kidney disease but limited evidences published in the peritoneal dialysis (PD) population. This study aimed to explore the long-term effects of TM on the mortality and technique failure.The Peritoneal Dialysis Telemedicine-assisted Platform Cohort Study (PDTAP Study) was conducted prospectively in 27 hospitals in China since 2016. Patient and practice data were collected through the doctor-end of the TM app (Manburs) for all participants. TM including self-monitoring records, on-line education materials, and real-time physician-patient contact was only performed for the patient-end users of the Manburs. The primary outcome was all-cause mortality. The secondary outcomes were cause-specific mortality and all-cause and cause-specific permanent transfer to hemodialysis.A total of 7,539 PD patients were enrolled between June 2016 and April 2019, with follow-up till December 2020. Patients were divided into two cohorts: TM group (39.1%) and non-TM group (60.9%). A propensity score was used to create 2,160 matched pairs in which the baseline covariates were well-balanced. There were significantly lower risks of all-cause mortality (HR 0.59 [0.51, 0.67], p < 0.001), CVD mortality (HR 0.59 [0.49, 0.70], p < 0.001), all-cause transfer to hemodialysis (0.57 [0.48, 0.67], p < 0.001), transfer to hemodialysis from PD-related infection (0.67 [0.51, 0.88], p = 0.003), severe fluid overload (0.40 [0.30, 0.55], p < 0.001), inadequate solute clearance (0.49 [0.26, 0.92], p = 0.026), and catheter-related noninfectious complications (0.41 [0.17, 0.97], p = 0.041) in the TM group compared with the non-TM group.This study indicated real-world associations between TM usage and reduction in patient survival and technique survival through a multicenter prospective cohort.© 2022 S. Karger AG, Basel.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 3 区 医学
小类 | 3 区 泌尿学与肾脏学
最新[2023]版:
大类 | 3 区 医学
小类 | 2 区 泌尿学与肾脏学
JCR分区:
出版当年[2021]版:
Q1 UROLOGY & NEPHROLOGY
最新[2023]版:
Q1 UROLOGY & NEPHROLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health, Key Laboratory of Renal Disease, Ministry of Education, Beijing, China.
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82494 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号